FDA approves wearable infusion device for advanced Parkinson disease
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
FDA approves Symbravo for acute treatment of migraine in adults
The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...
InMode Ltd. (INMD) Q4 2024 Earnings Call Transcript
Q4 2024 Results Conference Call February 4, 2025 8:30 AM ETCompany ParticipantsMiri Segal - CEO, MS-IRMoshe Mizrahy - ...
Earnings call transcript: InMode Q4 2024 results miss forecasts
InMode Ltd (NASDAQ:INMD) reported its financial results for the fourth quarter of 2024, revealing a shortfall in both earnings and revenue compared to market expectations. The company's earnings per ...